These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2180 related items for PubMed ID: 15811980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA.
    JAMA; 2007 Jan 10; 297(2):169-76. PubMed ID: 17213400
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D, Koenig W, Brenner H.
    Arch Intern Med; 2007 Jan 10; 166(22):2455-60. PubMed ID: 17159010
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.
    Atherosclerosis; 2013 Jun 10; 228(2):478-84. PubMed ID: 23582589
    [Abstract] [Full Text] [Related]

  • 6. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar 10; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.
    Circulation; 2005 Jul 05; 112(1):110-6. PubMed ID: 15983245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
    Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, Breteler MM, Witteman JC, van den Meiracker AH.
    Hypertension; 2010 Mar 05; 55(3):785-91. PubMed ID: 20083731
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L.
    Circulation; 2003 Jul 22; 108(3):275-81. PubMed ID: 12847065
    [Abstract] [Full Text] [Related]

  • 16. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J, CLARICOR Trial Group.
    Scand J Clin Lab Invest; 2011 Feb 22; 71(1):52-62. PubMed ID: 21108561
    [Abstract] [Full Text] [Related]

  • 17. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 22; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 18. Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort.
    Frary CE, Blicher MK, Olesen TB, Stidsen JV, Greve SV, Vishram-Nielsen JK, Rasmussen SL, Olsen MH, Pareek M.
    Eur J Prev Cardiol; 2020 Apr 22; 27(6):570-578. PubMed ID: 31718257
    [Abstract] [Full Text] [Related]

  • 19. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, von Beckerath O, Vogt W, Schömig A.
    Am J Med; 2006 Apr 22; 119(4):355.e1-8. PubMed ID: 16564781
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 22; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 109.